Podstory DiabeFoot XVII — Diabetic-Friendly EVA Sandals

The Podstory DiabeFoot XVII is specifically formulated for individuals managing Type 1 and Type 2 diabetes, where peripheral neuropathy, impaired circulation, and reduced immune response create extreme vulnerability to pressure sores, blisters, and ulceration from ill-fitting footwear. The interior surface of the sandal is entirely seamless, eliminating every potential friction point that could initiate skin breakdown on neuropathic feet that cannot detect developing abrasion through normal pain signaling. The extra-depth footbed accommodates custom orthotics and prescribed total contact insoles up to 14 mm in thickness without requiring size modification to the sandal outer dimensions. EVA foam specification meets the APMA (American Podiatric Medical Association) Seal of Acceptance criteria for diabetic footwear, achieving a compression set of less than 12% after 72 hours of continuous loading at body weight. Pressure mapping data collected from 80 diabetic subjects demonstrates peak plantar pressure reduction of 42% compared to flat EVA control sandals, achieved through strategic forefoot offloading geometry. Antimicrobial silver ion treatment on the footbed surface inhibits Staphylococcus aureus, Escherichia coli, and Candida albicans at greater than 99.9% reduction within 24 hours. Temperature-indicating foam changes color from white to pale yellow when foot skin temperature exceeds 33 degrees Celsius, an early warning sign of developing Charcot foot inflammation. Physician prescription compatible and HSA/FSA eligible in the United States. Weight per pair: 240 g in size US 9.